CPHI SOUTH EAST ASIA 2026

CPHI South East Asia 2026: Catalyzing Innovation in Bangkok's Pharma Hub

Scheduled for July 8–10, 2026, in Bangkok, Thailand, CPHI South East Asia returns as Southeast Asia’s premier pharmaceutical networking and trade event. As the region’s pharmaceutical market accelerates—driven by rising healthcare demands, generic production, and biotech advancements—this gathering serves as a critical nexus for industry leaders, innovators, and regulators.

Event Highlights
CPHI South East Asia 2026 will unite over 10,000 attendees and 500+ exhibitors from 90+ countries, showcasing the full pharma value chain. The exhibition floor will feature:
- Ingredients & APIs: Suppliers of active pharmaceutical ingredients (APIs), excipients, and intermediates.
- Contract Development & Manufacturing (CDMOs): Partners for outsourcing, formulation, and packaging.
- Technology & Equipment: Cutting-edge machinery for automation, quality control, and sustainability.
- Digital Health & Biotech: Innovations in AI-driven drug discovery, biologics, and personalized medicine.

Conference & Insights
Parallel to the exhibition, a high-level conference will address pivotal industry themes:
- Regulatory Harmonization: Updates on ASEAN’s evolving pharmaceutical regulations and compliance.
- Supply Chain Resilience: Strategies for mitigating disruptions and ensuring API security.
- Sustainability in Pharma: Green manufacturing, waste reduction, and ESG compliance.
- Market Expansion: Opportunities in Thailand’s growing medical tourism and neighboring ASEAN markets.

Why Bangkok?
Thailand’s strategic location, advanced healthcare infrastructure, and government support for the "Bio-Circular-Green Economy" (BCG) model make it ideal for this event. Bangkok’s accessibility—via Suvarnabhumi Airport—and vibrant business ecosystem foster seamless networking and collaboration.

Who Should Attend?
- Pharma Executives: CEOs, COOs, and R&D heads seeking growth partners.
- Regulatory Experts: Compliance officers and policymakers shaping regional standards.
- Startups & SMEs: Innovators showcasing disruptive technologies.
- Investors: Venture capitalists scouting for mergers and acquisitions.

Expected Impact
CPHI South East Asia 2026 is projected to generate $500M+ in business deals, accelerate technology adoption, and position Bangkok as a pharma innovation hub. Attendees will gain actionable insights, forge cross-border partnerships, and contribute to Southeast Asia’s goal of becoming a self-sufficient pharmaceutical powerhouse.

Mark your calendars for July 8–10, 2026, in Bangkok—where global pharma meets regional ambition.